LeafNLP Demos
Back to explore

Report #2877420

Received Dec 11, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NC
Recovered
Unknown
Vaccinated
Oct 3, 2025
Onset
Oct 3, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKHD249LA

Symptoms (2)

No adverse eventProduct preparation issue

Symptom narrative

only the diluent of Shingrix was administered to the patient.; only the diluent of Shingrix was administered to the patient.; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number HD249, expiry date 28-APR-2027) for prophylaxis. Concomitant products included pravastatin. On 03-OCT-2025, the patient received Shingrix (left deltoid). On 03-OCT-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: only the diluent of Shingrix was administered to the patient.) and inappropriate dose of vaccine administered (Verbatim: only the diluent of Shingrix was administered to the patient.). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date 5-DEC-2025 It was reported that only received the diluent of Shingrix was administered to the patient. No adverse events were observed following the administration.

Other medications

PRAVASTATIN